Fermented plant-based diet for gut health and colitis
Official title: Fermented Vegan Optimized Diet in Health and Colitis
Run by Region Skane · NCT06696222 · Data updated 2026-11-12
This project will test whether a fermented, plant-based (vegan) diet improves gut barrier function and symptoms in people with ulcerative colitis or Crohn's disease and in healthy volunteers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | Region Skane Academic / other |
| Locations | 2 sites (Malmö and 1 other locations) |
| Status | Recruiting |
| Started | November 18, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT06696222 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with ulcerative colitis or Crohn's disease who have not had extensive bowel surgery, as well as healthy adults without chronic illnesses or regular medications, and all participants must not have used antibiotics in the past month.
✕Probably not a fit
People who recently took antibiotics, have had extensive bowel surgery, have other chronic diseases requiring medication, or have severe unstable IBD are unlikely to receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial compares a fermented, plant-based diet (including vegetarian yogurt and meat alternatives) with an ordinary meat-containing diet and placebo products in both healthy volunteers and people with IBD (ulcerative colitis or Crohn's disease). Participants follow the assigned diet for a set period while investigators collect stool, blood, and clinical data to measure mucus barrier integrity, microbiota composition, and short-chain fatty acid production. Key exclusions include antibiotic use in the past month and, for IBD participants, previous extensive bowel surgery. The trial aims to see if replacing processed animal products with fermented plant-based alternatives increases mucus production, reduces bacterial translocation, and improves symptoms.
Why it matters
Potential benefit: If successful, the diet could strengthen the gut mucus barrier, boost beneficial microbiome metabolites like short-chain fatty acids, and reduce intestinal inflammation and symptoms for people with IBD.
How similar studies have gone: Smaller studies and observational data suggest high-fiber and fermented foods can modify the microbiome and sometimes improve symptoms, but large controlled trials in IBD are limited and results have been mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy volunteers in two groups * IBD in two groups (ulcerative colitis or Crohn's disease) Exclusion Criteria: * For healthy any disease requiring medication * For IBD previous extensive operation * For both antibiotics the past month
Where it's running
-
Dept of Gastroenterology
Malmö, Sweden Recruiting -
Dept of Gastroenterology
Malmö, Sweden Recruiting
Study contacts
- Principal investigator: Klas Sjöberg, Adj prof — Dept of Gastroenterology
- Study coordinator: Klas Sjöberg, Adj prof
- Email: klas.sjoberg@med.lu.se
- Phone: +46 40 33 61 61
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
DISC-0974-201 for adults with IBD-related anemia
This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.
-
Moderate breathing and movement: Can regular exercise help people with quiescent inflammatory bowel disease feel better?
This trial tests whether a moderate-intensity exercise program improves quality of life for adults with Crohn's disease or ulcerative colitis who are currently in clinical remission.
-
Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis in Remission
This study tests whether a Mediterranean diet, with or without an 8-hour eating window, helps gut health and quality of life in adults with ulcerative colitis in remission.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Wearable data to spot IBD flareups in people with ulcerative colitis or Crohn's disease
This study tests whether heart‑rate variability from participants’ own wearables can help predict IBD flares.
-
PVT401 in healthy adults
This trial will test intravenous PVT401 in healthy adults who carry the HLA DRB4*0101 or DRB4*0103 allele to see how the drug behaves in the body and whether single and multiple doses are safe.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.